1434 results Stibbe advises Tessenderlo Group Stibbe advised Tessenderlo Group on the issuance and public offering of bonds to retail investors for the amount of EUR 250 million. Stibbe advises a company in the chemical industry Stibbe advises a company in the chemical industry on a regulation case about safety standards. Stibbe advises a transport organisation Advising a transport organisation on the implementation of new regulation standards. Stibbe advises a financial organisation Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator. Stibbe advises on the notes offerings of Fiat Chrysler Advising J.P. Morgan and the other underwriters on the notes offerings of Fiat Chrysler Automobiles N.V. for a total amount of USD 3.0 billion. Stibbe advises FOD Economie Representing the Belgian Ministry of Economy in a high-profile lawsuit against SABAM (the Belgian Society of Authors, Composers and Publishers) before the Brussels courts concerning the private collecting society’s compliance with the Belgian Copyright Ac Stibbe advises a large municipality Stibbe advises companies with regard to investigations of the Social Affairs and Employment (SAE) Inspectorate Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act. Stibbe advises Belgacom, T-Systems International GmbH, Strabag AG and Efkon AG Stibbe assisted a consortium composed of Belgacom, T-Systems International GmbH, Strabag AG, and Efkon AG with the preparation of its bid and with the negotiations and subsequent closing of the contract for the realization of the ETCS PPR project. Stibbe advises municipality of Waddinxveen Stibbe advises on the equity offering of Fiat Chrysler Stibbe advises J.P. Morgan and the other underwriters on the equity offering of Fiat Chrysler Automobiles N.V. Stibbe advises Tessenderlo Chemie Stibbe advised Euronext Brussels’ listed Tessenderlo Chemie NV on its EUR 175 million rights’ offering and capital increase, backed by its reference shareholder Picanol NV. Stibbe advises on the convertible bond offering of NXP Semiconductors Advising the underwriters on the USD 1 billion convertible bond offering of NXP Semiconductors Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann. Stibbe advises Intermixt Stibbe advises Intermixt as the representative of the Flemish municipalities of the so-called mixed energy distribution sector with respect to the withdrawal of Electrabel from the Flemish electricity and gas distribution system operators. Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. Stibbe advises on the IPO of IMCD Stibbe advises on the IPO of Euronext Pagination Previous page Page 70 Current page 71 Page 72 Page 73 Next page
Stibbe advises Tessenderlo Group Stibbe advised Tessenderlo Group on the issuance and public offering of bonds to retail investors for the amount of EUR 250 million.
Stibbe advises a company in the chemical industry Stibbe advises a company in the chemical industry on a regulation case about safety standards.
Stibbe advises a transport organisation Advising a transport organisation on the implementation of new regulation standards.
Stibbe advises a financial organisation Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator.
Stibbe advises on the notes offerings of Fiat Chrysler Advising J.P. Morgan and the other underwriters on the notes offerings of Fiat Chrysler Automobiles N.V. for a total amount of USD 3.0 billion.
Stibbe advises FOD Economie Representing the Belgian Ministry of Economy in a high-profile lawsuit against SABAM (the Belgian Society of Authors, Composers and Publishers) before the Brussels courts concerning the private collecting society’s compliance with the Belgian Copyright Ac
Stibbe advises companies with regard to investigations of the Social Affairs and Employment (SAE) Inspectorate Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act.
Stibbe advises Belgacom, T-Systems International GmbH, Strabag AG and Efkon AG Stibbe assisted a consortium composed of Belgacom, T-Systems International GmbH, Strabag AG, and Efkon AG with the preparation of its bid and with the negotiations and subsequent closing of the contract for the realization of the ETCS PPR project.
Stibbe advises on the equity offering of Fiat Chrysler Stibbe advises J.P. Morgan and the other underwriters on the equity offering of Fiat Chrysler Automobiles N.V.
Stibbe advises Tessenderlo Chemie Stibbe advised Euronext Brussels’ listed Tessenderlo Chemie NV on its EUR 175 million rights’ offering and capital increase, backed by its reference shareholder Picanol NV.
Stibbe advises on the convertible bond offering of NXP Semiconductors Advising the underwriters on the USD 1 billion convertible bond offering of NXP Semiconductors
Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann.
Stibbe advises Intermixt Stibbe advises Intermixt as the representative of the Flemish municipalities of the so-called mixed energy distribution sector with respect to the withdrawal of Electrabel from the Flemish electricity and gas distribution system operators.
Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.